GENinCode (LON:GENI) Hits New 1-Year Low – Here’s Why

Shares of GENinCode Plc (LON:GENI) reached a new 52-week low during trading on Monday. The company traded as low as GBX 0.56 and last traded at GBX 0.64, with a volume of 1,374,834 shares traded. The stock had previously closed at GBX 0.64.

GENinCode Price Performance

The stock’s 50 day simple moving average is GBX 0.84 and its 200-day simple moving average is GBX 0.95. The firm has a market cap of £4.81 million, a price-to-earnings ratio of -0.50 and a beta of 0.59. The company has a debt-to-equity ratio of 4.75, a quick ratio of 15.88 and a current ratio of 2.22.

GENinCode (LON:GENI) last posted its quarterly earnings data on Tuesday, September 29th. The company reported GBX (0.38) EPS for the quarter. GENinCode had a negative return on equity of 481.34% and a negative net margin of 202.42%. Equities research analysts anticipate that GENinCode Plc will post -7.13 EPS for the current fiscal year.

GENinCode Company Profile

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.